Beyond HSV-1: Pseudorabies Virus as a Next-Generation Seronegative Backbone for Oncolytic Virotherapy
Microorganisms · 12.11.2026 · 14 (11) · 2627
DOI: 10.3390/microorganisms14112627 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 12.11.2026. Verfasst von Anna Aubareda und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Oncolytic virotherapy has emerged as a promising strategy to combat cancer by exploiting viruses that selectively replicate in and destroy tumour cells. Among herpesviruses, herpes simplex virus type 1 (HSV-1) has served as the most extensively studied platform for the development of genetically engineered oncolytic viruses (OVs). However, its neurovirulence and widespread human seroprevalence pose safety concerns. Pseudorabies virus (PRV), a swine alphaherpesvirus not naturally pathogenic to humans, offers a compelling alternative. This review explores PRV’s biological features, mechanisms of cell entry, and genetic manipulability, highlighting its potential as a safe and versatile oncolytic platform. Advances in attenuation strategies, promoter targeting, and tropism modulation have enabled the development of recombinant PRVs with tumour-selective replication and reduced neurovirulence. Furthermore, PRV vectors armed with immunomodulatory transgenes have demonstrated potent antitumour efficacy and immune activation in preclinical models. Collectively, these findings position PRV as a promising candidate for next-generation oncolytic virotherapy, with potential to complement existing platforms.
Zitieren
APA
Aubareda, A., & Gómez-Sebastián, S. (2026). Beyond HSV-1: Pseudorabies Virus as a Next-Generation Seronegative Backbone for Oncolytic Virotherapy. Microorganisms, 14(11), 2627. https://doi.org/10.3390/microorganisms14112627
Vancouver
Aubareda A, Gómez-Sebastián S. Beyond HSV-1: Pseudorabies Virus as a Next-Generation Seronegative Backbone for Oncolytic Virotherapy. Microorganisms. 2026;14(11):2627. doi:10.3390/microorganisms14112627
BibTeX
@article{Aubareda2026,
author = {Aubareda, Anna and Gómez-Sebastián, Silvia},
title = {Beyond HSV-1: Pseudorabies Virus as a Next-Generation Seronegative Backbone for Oncolytic Virotherapy},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {11},
pages = {2627},
doi = {10.3390/microorganisms14112627}
}
EUVIMED